The FDA has revised its draft guidance on content and formatting for Risk Evaluation and Mitigation Strategy documents to highlight who is responsible for each required action, rather than just the listing the statutory elements from the Food and Drug Administration Amendments Act of 2007.
Source: Drug Industry Daily